Ainos, Inc.

Ainos, Inc. is a healthcare company specializing in medical technologies for point-of-care testing and novel medical treatments. The company generates revenue through the sale of its COVID-19 antigen rapid test kit, cloud-based test management App, COVID-19 nucleic acid test, volatile organic compounds point-of-care testing, Very Low-Dose Oral Interferon Alpha, and Synthetic RNA technology platform. Ainos, Inc. focuses on developing and commercializing innovative medical solutions for disease indications, providing essential tools for healthcare professionals and individuals to manage and treat various medical conditions.

Products

• COVID-19 antigen rapid test kit

• Cloud-based test management App

• COVID-19 nucleic acid test

• Volatile organic compounds point-of-care testing

• Very Low-Dose Oral Interferon Alpha

• Synthetic RNA technology platform